La Roche Blanche, France

Arlette Darfeuille-Michaud

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2013-2015

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Arlette Darfeuille-Michaud

Introduction

Arlette Darfeuille-Michaud, a distinguished inventor based in La Roche Blanche, France, has made significant strides in the field of medical innovation, particularly in the study and treatment of Crohn's disease. With a robust portfolio of three patents, her research has opened new avenues for diagnosing and managing inflammatory bowel diseases.

Latest Patents

Arlette's latest patents include groundbreaking methodologies and treatments for Crohn's disease. The first patent presents an in vitro method for diagnosing the condition by identifying an overexpression of the CD66c receptor in individuals at risk or suffering from the disease. This invention not only highlights a diagnostic approach but also paves the way for both preventive and curative treatments for Crohn's disease.

Additionally, her second notable patent focuses on antagonists designed to prevent or treat inflammatory bowel disease, specifically targeting the interaction between the Gp96 receptor and AIEC strains. This innovation includes pharmaceutical compositions containing such antagonists, which may be antibodies against Gp96 or OmpA proteins, and further outlines a method for diagnosing inflammatory bowel disease or determining predisposition to these conditions.

Career Highlights

Throughout her career, Arlette has collaborated with notable organizations, including Lesaffre Et Compagnie and Université du Droit et de la Santé Lille 2. Her diverse experiences in these institutions have contributed to her profound understanding of medical research and innovation, enabling her to produce impactful patents in her field.

Collaborations

Arlette has worked alongside esteemed colleagues, including Jean-Luc Simon and Georges Pignede. These collaborations have enriched her work and allowed for the exchange of ideas that are crucial in scientific achievements. The synergistic efforts with her coworkers exemplify the importance of teamwork in advancing medical research and innovation.

Conclusion

Arlette Darfeuille-Michaud's inventiveness demonstrates her commitment to advancing healthcare solutions. Her contributions are particularly vital to patients suffering from Crohn's disease, providing new diagnostics and treatment options that could improve their quality of life. With her ongoing research and innovative spirit, Arlette continues to make significant impacts in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…